Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial. - Starling, Amaal J.; Kudrow, David; Kapur, Neha; Awad, Susanne F.; Grossman, S. Wald; Patel, Foram; Ailani, Jessica; Blumenfeld, Andrew; Lipton, Richard B. (Pain & Therapy, 2026)